1. Home
  2. PMTS vs ZNTL Comparison

PMTS vs ZNTL Comparison

Compare PMTS & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

HOLD

Current Price

$24.08

Market Cap

332.4M

Sector

Finance

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

N/A

Current Price

$3.16

Market Cap

289.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMTS
ZNTL
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.4M
289.0M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PMTS
ZNTL
Price
$24.08
$3.16
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$27.67
$6.60
AVG Volume (30 Days)
152.4K
866.0K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.03
EPS
0.34
N/A
Revenue
$312,189,000.00
N/A
Revenue This Year
$9.95
N/A
Revenue Next Year
$10.02
N/A
P/E Ratio
$66.18
N/A
Revenue Growth
12.27
N/A
52 Week Low
$10.81
$1.21
52 Week High
$31.25
$6.95

Technical Indicators

Market Signals
Indicator
PMTS
ZNTL
Relative Strength Index (RSI) 40.27 35.78
Support Level $16.21 $3.48
Resistance Level $31.25 $4.06
Average True Range (ATR) 1.15 0.18
MACD -0.84 -0.01
Stochastic Oscillator 29.35 8.05

Price Performance

Historical Comparison
PMTS
ZNTL

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: